Skip to content

Evaluating the Impact of WHO Trauma Care Checklist on Clinical Outcome of Patients

Evaluating the Impact of World Health Organization Trauma Care Checklist on Clinical Outcome of Patients: A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06944340
Enrollment
60
Registered
2025-04-25
Start date
2025-04-26
Completion date
2025-09-01
Last updated
2025-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma, Trauma Related Injuries

Keywords

Trauma, Trauma Outcomes, WHO Trauma Care Checklist, Trauma Checklist, Injury, Emergency Care

Brief summary

This study is being conducted at the Department of Trauma and Orthopedics at Khyber Teaching Hospital, Peshawar. It will test whether using the World Health Organization (WHO) Trauma Care Checklist can help improve the care and recovery of patients who have experienced physical injuries (trauma). Injuries are a major cause of death and disability, especially in countries like Pakistan. When someone is seriously injured, doctors must act quickly and carefully to save lives and prevent long-term problems. Checklists are simple tools that help healthcare providers make sure nothing is missed during treatment. In this study, adult trauma patients will be randomly divided into two groups: One group will receive the standard trauma care (Group A). The other group will receive trauma care with the help of the WHO checklist (Group B). Doctors will compare the outcomes of both groups by looking at things like pain levels, injury severity, recovery progress, complications (like infections or organ problems), and overall satisfaction. The goal is to see if the checklist makes a meaningful difference in patient recovery and safety.

Detailed description

Background Trauma is one of the leading causes of mortality and long-term disability worldwide. In Pakistan, the burden of traumatic injuries is significant, especially among younger individuals. Contributing factors include road traffic accidents, workplace injuries, natural disasters, and violence. Despite being preventable and manageable in many cases, the lack of standardized emergency protocols and system-level interventions has resulted in suboptimal trauma care and increased complications. The WHO developed the TCC to support healthcare providers in delivering consistent, high-quality trauma care, especially in resource-limited settings. Objective This study aims to evaluate whether implementing the WHO Trauma Care Checklist during the initial assessment and management of trauma patients improves clinical outcomes compared to standard care alone. The primary hypothesis is that the checklist will help reduce complications, improve injury assessment accuracy, and enhance patient satisfaction. Study Design and Setting This is a prospective, single-blinded, randomized controlled trial being conducted at the Department of Trauma and Orthopedics, Khyber Teaching Hospital, Peshawar. The study will be conducted over six months following ethical approval. Participants A total of 60 adult trauma patients (aged 18-60 years) who meet specific inclusion criteria will be enrolled using simple random sampling. Participants will be randomly allocated to one of two groups: Group A: Standard trauma care without the WHO checklist Group B: Standard trauma care with the WHO checklist Patients with severe comorbidities, pregnancy, chemotherapy, chronic mental illness, or substance abuse will be excluded. Intervention The WHO Trauma Care Checklist will be used by the clinical team during the initial management of patients in Group B. The checklist includes key safety steps related to airway, breathing, circulation, disability assessment, and exposure/environment, along with other evidence-based practices to prevent missed injuries and reduce medical errors. Data Collection and Tools Baseline demographic and clinical data will be collected at admission. Outcome assessments will include: Improvement in Injury Severity Score (ISS) Visual Analogue Scale (VAS) for pain Glasgow Coma Scale (GCS) Duration of hospital stay and number of bed-bound days Occurrence of complications (e.g., sepsis, renal failure, pneumonia, wound infection) Mortality Missed injuries at presentation Patient satisfaction (rated on a 1-10 scale) Medical charts, direct observation, and patient interviews will serve as the primary data sources. Injury severity will be assessed by trained researchers using a standardized scoring system. Follow-Up Patients will be followed during their hospital stay and for one month post-discharge through phone calls or in-person visits. All outcomes will be assessed both at discharge and during the follow-up period. Data Analysis SPSS will be used for statistical analysis. Descriptive statistics will summarize patient characteristics and clinical outcomes. Independent t-tests and chi-square tests will compare outcomes between groups. A significance level of p \< 0.05 will be used. Significance The results of this trial will help determine whether the WHO Trauma Care Checklist improves trauma care quality and outcomes in a low-resource hospital setting. If effective, the checklist could be implemented more widely to enhance trauma care across similar settings.

Interventions

OTHERWHO Trauma Care Checklist

A standardized checklist developed by the WHO for trauma care, designed to reduce errors and ensure compliance with critical steps in trauma management. Implemented by trained clinicians during patient assessment and treatment phases. Components include verification of patient identity, assessment of airway/breathing/circulation, pain management, monitoring for missed injuries, and post-resuscitation care. Checklist use is documented in medical records.

Sponsors

Khyber Teaching Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Two-group, single-blinded, parallel assignment randomized controlled trial. Patients are randomly allocated to either receive standard trauma care (control group) or standard care enhanced with the WHO Trauma Care Checklist (intervention group). Outcomes are compared between groups over a 1-month follow-up period.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 60 years old * Glasgow Coma Scale (GCC) equal to or more than 10 * Consenting to participate in the study

Exclusion criteria

* Patients who do not meet the inclusion criteria * Patients who refrain from continuing the study * Patients with the incomplete checklist * Pregnancy * History of chronic mental illness, lung or kidney disease * Undergoing chemotherapy. * Illicit drug dependency

Design outcomes

Primary

MeasureTime frameDescription
Improvement in Injury Severity Score (ISS)Assessed at admission and after initial management.difference in ISS at admission and after initial management. A higher difference means a better outcome.
Glasgow Coma Scale (GCS) ScoreMeasured at presentation and 1 hour post-treatment.Consciousness levels of participant. Average change/rise/fall. Higher GCS means better outcome
level of PainAssessed after initial management.Pain levels using the Visual Analogue Scale (VAS). A lower VAS score means better outcome.

Secondary

MeasureTime frameDescription
All-Cause Mortality Rate1 month post-treatment.Incidence of death within 1 month post-trauma.
Incidence of Post-Trauma Complications1 month post-treatmentRates of complications (e.g., cardiac arrest, pneumonia, pulmonary embolism, sepsis, wound infections).
Number of Bed-Bound DaysFrom admission to discharge (up to 1 month)Duration of immobilization during hospitalization
Patient Satisfaction ScoreAssessed at 1 month follow-up.Patient-reported satisfaction with care quality on a scale of 1-10. Higher scores mean better outcomes.
Rate of Missed InjuriesIdentified during 1-month follow-up.Proportion of injuries undetected during initial assessment.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026